Longjumeau, France 4/20/09—Horiba Jobin Yvon has acquired GenOptics, a provider of surface plasmon resonance imaging technology (SPRi) for label-free detection for an undisclosed amount. “In the coming years we will see the merging of biotechnology and microtechnology to create combinations of ultra integrated devices on a molecular scale” stated Dr. Michel Mariton, HORIBA Scientific segment […]
In April, all major US stock indexes climbed higher despite weak economic data and mixed first-quarter earnings. The Dow Jones Industrial Average, S&P 500 and NASDAQ finished the month up 7.3%, 9.4% and 12.3%, respectively. The markets shrugged off higher than expected unemployment claims, increasing foreclosure rates and the report of a 6.1% annual decline […]
This year, the EPA will begin to implement the Endocrine Disruptor Screening Program (EDSP), which was established in 1998. Initially, 67 pesticide active ingredients and high-production volume chemicals used as pesticide inert ingredients will be screened. Tier 1 of the EDSP will screen the substances for interactions with estrogen, androgen or thyroid hormone systems. Substances […]
Microfluidics, or lab-on-a-chip systems, have been somewhat pigeonholed as being a technology for capillary electrophoresis, particularly with the success of the Agilent 2100 Bioanalyzer and Caliper Life Sciences’ LabChip products. However, the use of microfluidic technology in LC has grown rapidly during the past several years. Agilent introduced the first chip-based LC/MS system in 2005, […]
Newark, CA 4/23/09; Paris, France 4/24/09—GE has signed a definitive agreement to sell an 81% stake in GE Security’s Homeland Protection business to high-technology firm SAFRAN for $580 million. GE will retain a 19% stake. GE’s Homeland Protection business consists of products for checked-baggage screening, military and critical infrastructure protection, as well as products for […]
Appeals US federal appeals courts have ruled on two long running patent infringement cases involving Applied Biosystems and Waters. Last fall, the US District Court of Appeals for the Federal Circuit ruled on appeals brought by Cohesive Technologies (now Thermo Fisher Scientific) and Waters related to Cohesive’s 1998 suit against Waters (see IBO 12/15/98). In […]
Waltham, MA 4/22/09—Phase Forward, a supplier of clinical trials software, has acquired Waban Software for $14 million in cash. Waban’s products include clinical data analysis systems, as well as lab information and clinical specimen management systems. In 2008, Waban had $4 million in revenues and break even operating income. Based in Cambridge, Massachusetts, with operations […]
Company Announcements Caprotec bioanalytics GmbH named Funakoshi as the exclusive distributor of its research products in Japan. Agilent announced in February that it will exclusively distribute and provide marketing and support for Protein Discovery’s PPS Silent Surfactant, an acid-cleavable, zwitterionic detergent for sample preparation prior to MS. In February, OriGene Technologies announced that it raised […]
Company Announcements STARLIMS Technologies’ 2008 sales rose 6.2% to $25.2 million (see IBO 3/31/09). Product revenue grew 11.3% to $15.5 million, and Service revenue declined 1.1% to $9.8 million. Adjusted operating income fell 30.2% to $3.0 million. Sales to public-sector labs accounted for 39% of revenues, manufacturing customers accounted for 25% of sales. Revenue from […]
Jena, Germany 4/30/09—Analytik Jena AG will acquire Biometra GmbH from Whatman GmbH, which is owned by GE Healthcare, in an all-cash transaction. Further financial details were not disclosed. Biometra develops and provides products for thermocycling, electrophoresis, blotting, gel imaging and hybridization. The company’s sales in recent years have been steady at around €9.0 million ($13.2 […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
